Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
US6300492A · kind A · utility
12Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2000 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Jul 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.